Literature DB >> 30020878

New Insights Into the Role of Tissue Eosinophils in the Progression of Colorectal Cancer: A Literature Review.

Ana Laura Saraiva1, Fátima Carneiro2.   

Abstract

INTRODUCTION: Amongst the inflammatory cells implicated in the immune surveillance of colorectal cancer, a growing body of evidence suggests a role for eosinophils in carcinogenesis. We aimed to review the value of tumour-associated tissue eosinophilia (TATE) in the prognosis of colorectal cancer emphasizing the identification and measurement of tissue-infiltrating eosinophils and their association with the clinicopathological features of the disease.
MATERIAL AND METHODS: We used PubMed and Web of Science search engines to retrieve studies that looked at the association between tissue eosinophils and colorectal cancer prognosis.
RESULTS: We selected 15 studies for our review. In the majority of the studies, eosinophils were identified in hematoxylin-eosin stained sections and scores were generated for analysis. Most of the studies pointed to tumour-associated tissue eosinophilia as a favourable prognostic marker in colorectal cancer and found an inverse association between eosinophil count and the metastatic potential of these neoplasms. The association between tumour-associated tissue eosinophilia and established prognostic markers of colorectal cancer was assessed in some studies, with inconsistent results. Additionally, tumour-associated tissue eosinophilia decreased with the adenoma-carcinoma progression of colorectal lesions. DISCUSSION: Several mechanisms have been proposed regarding eosinophil chemoatraction to tumour tissues and eosinophil-cancer cell cross-talk, suggesting that eosinophils are actively involved in colorectal cancer progression. Although a scoring system is still lacking, tumour-associated tissue eosinophilia meets the criteria of a convenient histopathological prognosticator in colorectal cancer.
CONCLUSION: Collectively, current evidence associates the presence of eosinophils in the colorectal cancer microenvironment with the modulation of tumour progression. The clinical impact of this finding deserves future research.

Entities:  

Keywords:  Colorectal Neoplasms; Eosinophils; Precancerous Conditions; Prognosis

Mesh:

Year:  2018        PMID: 30020878     DOI: 10.20344/amp.10112

Source DB:  PubMed          Journal:  Acta Med Port        ISSN: 0870-399X


  5 in total

1.  Simultaneous LC-MS/MS-Based Quantification of Free 3-Nitro-l-tyrosine, 3-Chloro-l-tyrosine, and 3-Bromo-l-tyrosine in Plasma of Colorectal Cancer Patients during Early Postoperative Period.

Authors:  Mariusz G Fleszar; Paulina Fortuna; Marek Zawadzki; Bogna Kosyk; Małgorzata Krzystek-Korpacka
Journal:  Molecules       Date:  2020-11-05       Impact factor: 4.411

2.  Prognostic impact of eosinophils in peripheral blood and tumor site in patients with esophageal squamous cell carcinoma treated with concurrent chemoradiotherapy.

Authors:  Xiyue Yang; Lei Wang; Huan Du; Binwei Lin; Jie Yi; Xuemei Wen; Lidan Geng; Xiaobo Du
Journal:  Medicine (Baltimore)       Date:  2021-01-22       Impact factor: 1.889

3.  Augmentation of the RNA m6A reader signature is associated with poor survival by enhancing cell proliferation and EMT across cancer types.

Authors:  Jaeik Oh; Chanwoong Hwa; Dongjun Jang; Seungjae Shin; Soo-Jin Lee; Jiwon Kim; Sang Eun Lee; Hae Rim Jung; Yumi Oh; Giyong Jang; Obin Kwon; Joon-Yong An; Sung-Yup Cho
Journal:  Exp Mol Med       Date:  2022-07-06       Impact factor: 12.153

4.  Changes in peripheral blood eosinophils may predict colorectal cancer - A retrospective study.

Authors:  Yossi Rosman; Tzipi Hornik-Lurie; Keren Meir-Shafrir; Idit Lachover-Roth; Anat Cohen-Engler; Ariel Munitz; Ronit Confino-Cohen
Journal:  World Allergy Organ J       Date:  2022-10-01       Impact factor: 5.516

5.  IgG4 induces tolerogenic M2-like macrophages and correlates with disease progression in colon cancer.

Authors:  Galateja Jordakieva; Rodolfo Bianchini; Daniel Reichhold; Jakob Piehslinger; Alina Groschopf; Sebastian A Jensen; Ettore Mearini; Giuseppe Nocentini; Richard Crevenna; Gerhard J Zlabinger; Sophia N Karagiannis; Alexander Klaus; Erika Jensen-Jarolim
Journal:  Oncoimmunology       Date:  2021-02-08       Impact factor: 8.110

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.